The effectiveness rate of the Pfizer / BioNTech vaccine has changed! According to the breaking news in Reuters, the effectiveness rate of the Pfizer / BioNTech vaccine has been updated, depending on the Covid-19 variants that have emerged. The new efficiency of the vaccine was announced as 91%.
On the other hand, the vaccine was reported to be 100 percent effective in the South African variant called B1351.
In a joint statement from Pfizer and BioNTech
In a joint statement from Pfizer and BioNTech, Covid-19 vaccine was stated to be 91% effective in preventing the disease, it was stated that the data used in the update were collected from people who were vaccinated for six years.
While the vaccine was reported to be 100% effective in the South African variant called B1351, these data were relatively small for 800 people. It was underlined that the vaccine was obtained from the group.
While it was announced that the vaccine had an overall efficiency of 91.3%, the 95% efficacy rate achieved in November last year and achieved through clinical trials with 44 thousand people is due to variants that have increased worldwide since then.
Pfizer’s CEO, Albert Bourla, in his statement on the subject, the data of the updated efficiency rate were experiments with more than 12 thousand people. Stating that the most obtained and these data were obtained with the subjects who had both doses of the vaccine within 6 months, he stated that they would apply to the USA for full approval with these data.
In a statement made yesterday, BioNTech emphasized that the increasing number of cases across Europe is worrisome. Uğur Şahin, the founder of the company, said that the vaccines on hand should be used as soon as possible instead of stockpiling. “The risk of interruption in vaccination is very low due to a delay in supply,” Şahin said.
That is why, with the assurance that new vaccines will come every week, you should make all the vaccinations you have.